Neurocrine Biosciences
NBIX
#1426
Rank
NZ$26.57 B
Marketcap
NZ$264.27
Share price
1.22%
Change (1 day)
28.31%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company